Effects of intermittent hypobaric hypoxia on blood lipid concentrations in male coronary heart diseae patients

High Altitude Medicine and Biology

Volumn 3, Issue 3, 2002, Pages 277-282

  Tin'Kov, Aleksey N ^a   Aksenov, Valeriy A ^a  

^a ORENBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Acclimation to hypoxia; Altitude; Cholesterol; Hypobaric chamber; Myocardial infarction; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AIR QUALITY CONTROL; ALTITUDE ACCLIMATIZATION; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERGOMETER; FOLLOW UP; HEART INFARCTION; HOLTER MONITORING; HUMAN; HYPOBARISM; HYPOXIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANOXIA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TRIGLYCERIDES;

EID: 0036745915     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/152702902320604250     Document Type: Article

References (22)

1. Aitbaev K.A., Madaminov Ia.K., Meimanaliev T.S., Shleifer E.A., and Kim N.M. (1990). Study of the effect of migration to high-mountain regions on the blood lipoprotein system. Kosm. Biol. Aviakosm. Med. 24:45-46.
2. Aleshin I.A., Kots Ia.I., Tverdokhlib V.P., Galiautdinov G.S., Vdovenko L.G., Zabirov M.R., and Meerson F.Z. (1993). The nondrug treatment of hypertension patients by their adaptation to periodic hypoxia in a barochamber. Ter. Arkh. 65:23-29.
3. Aleshin I.A., Tin'kov A.N., Kots Ia.I., and Tverdokhlib V.P. (1997). Experience in treating patients with cardiovascular diseases by means of adaptation to periodic barochamber hypoxia. Ter. Arkh. 69:54-58.
4. de Mendoza S., Nucete H., Ineichen E., Salazar E., Zerpa A., and Glueck C.J. (1979). Lipids and lipoproteins in subjects at 1,000 and 3,500 meter altitudes. Arch. Environ. Health. 34:308-311.
5. Dominguez Coello S., Cabrera De Leon A., Bosa Ojeda F., Perez Mendez L.I., Diaz Gonzalez L., and Aguirre-Jaime A.J. (2000). High density lipoprotein cholesterol increases with living altitude. Int. J. Epidemiol. 29:65-70.
6. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., and Gotto A.M. Jr. (1998). Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AF-CAPS/TexCAPS: Air Force/Texas coronary atherosclerosis prevention study. JAMA. 279:1615-1622.
7. Dudukalo D.P., Ryzhuk V.V., Likov A.F., and Shkolenko R.L. (1987). Experience with the risk factor-based prevention of ischemic heart disease at a Pyatigorsk health resort. Ter. Arkh. 59:89-91.
8. Fiori G., Facchini F., Pettener D., Rimondi A., Battistini N., and Bedogni G. (2000). Relationships between blood pressure, anthropometric characteristics and blood lipids in high- and low-altitude populations from Central Asia. Ann. Hum. Biol. 27:19-28.
9. Frick M.H., Elo O., Haapa K., Heinonen O.P., Heinsalmi P., Helo P., Huttunen J.K., Kaitaniemi P., Koskinen P., Manninen V., Mäenpää H., Mälkönen M., Mänttäri M., Noroloa S., Pasternack A., Pikkarainen J., Romo M., Sjǒblom T., and Nikkilä E.A. (1987). Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 317:1237-1245.
10. Fujimoto N., Matsubayashi K., Miyahara T., Murai A., Matsuda M., Shio H., Suzuki H., Kameyama M., Saito A., and Shuping L. (1998). The risk factors for ischemic heart disease in Tibetan highlanders. Jpn. Heart J. 30: 27-34.
11. Gorbachenkov A.A., Tkachuk E.N., Erenburg I.V., Kondrykinskaia I.I., and Kotliarova L.A. (1994). Hypoxic training in prevention and treatment. Ter. Arkh. 66:28-32.
12. Klimov A.N. (1977). Preventive Cardiology. Medicine, Moscow, Russia, pp. 260-271.
13. Kondrykinskaya I.I., Tkatchouk E.N., Ehrenbourg I.V., Gorbachenkov A.A., and Lyapkov B.G. (1993). Interval hypoxic training effect on lipid metabolism in patients with primary hypercholesterolemia. Hyp. Med. J. 1:13-17.
14. Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N. Engl. J. Med. 339:1349-1357.
15. Meerson F.Z., Tverdokhlib V.P., and Nikonorov A.A. (1988). Prevention of atherogenic dislipoproteinemias and metabolic disorders in the liver in emotional-pain stress. Vopr. Med. Khim. 34:104-109.
16. Meerson F.Z., Tverdokhlib V.P., and Boev V.M. (1989). Adaptation to periodic hypoxia in treatment and prevention. Medicine, Moscow, Russia, pp. 26-33.
17. Mirrakhimov M.M., Aitbaev K.A., Murataliev T.M., and Kim N.M. (1991). Possibility of correcting atherogenic dyslipoproteinemia by the mountain climate treatment. Kardiologiia 31:8-10.
18. Murataliev T.M., Chaltabaev K.S., Aitbaev K.A., and Satkynalieva Z.T. (1991). The effect of climatic treatment in the central highlands on the lipid, cortisol, renin and aldosterone content of the blood in patients with an acute myocardial infarct. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult. Jan.-Feb. (1):23-27.
19. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., Brown L., Warnica JW., Arnold J.M., Wun C.C., Davis B.R., and Braunwald E. (1996). The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: cholesterol and recurrent events trial investigators. N. Engl. J. Med. 335:1001-1009.
20. Scandinavian Simvastatin Survival Study Group. (1994). Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1381-1389.
21. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., McKillop J.H., and Packard C.J. (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland coronary prevention study group. N. Engl. J. Med. 333:1301-1307.
22. Topuria D.I. (1975). Effects of multidisciplinary resort treatment in Kislovodsk on lipid metabolism in patients with coronary heart disease and a history of myocardial infarction. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult. 3:247-250.